| Trial Identifier: | AZ-RU-00011 |
| Sponsor: | AstraZeneca |
| Start Date: | March 2025 |
| Primary Completion Date: | March 2028 |
| Study Completion Date: | March 2029 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| RU | Chelyabinsk, RU, 454087 |
| RU | Moscow, RU, 115478 |
| RU | Moscow, RU, 111123 |
| RU | Moscow, RU, 115533 |
| RU | Moscow, RU, 125367 |
| RU | Moscow, RU, 125284 |
| RU | Moscow, RU, 117997 |
| RU | Saint Petersburg, RU, 197758 |
| RU | Yekaterinburg, RU, 620036 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company